All Stories

  1. PATIENT CONDITION MAY BE MORE IMPORTANT FOR SURVIVAL THAN MUTATIONAL ANALYSIS IN MDS

    Article • American Journal of Hematology, July 2017, Wiley

    Dr Fernando Ramos, MD PhD ELISA E LUÑO

  2. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)

    Article • American Journal of Hematology, May 2017, Wiley

    MD PhD ELISA E LUÑO , Dr Fernando Ramos, Xavier Calvo

  3. Excess mortality in the myelodysplastic syndromes

    Article • American Journal of Hematology, December 2016, Wiley

    Dr Fernando Ramos, MD PhD ELISA E LUÑO

  4. Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study

    Article • European Journal of Cancer Care, January 2016, Wiley

    Dr Fernando Ramos, MD PhD ELISA E LUÑO